Americans will be shielded from the impact of Pfizer’s decision to raise the price of the Covid-19 vaccine, the company’s CEO Albert Bourla said Wednesday.
The government lacks funding to accomplish core tenants of its Covid response, such as federally procuring Covid-19 vaccines and offering them free to Americans. Stalemates in Congress forced the government’s hand, causing them to rush commercialization before the pandemic conditions improved significantly.
“We want a very orderly transition,” from government purchasing to insurance market purchasing, White House Covid-19 response coordinator Ashish Jha said Tuesday, addressing the STAT Summit in Boston virtually. “We want to make ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.